Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome
Gil Klinger
*
, Paul Merlob
*
Corresponding author for this work
Pediatrics
Schneider Childrens Medical Center Israel
Tel Aviv University
Research output
:
Contribution to journal
›
Article
›
peer-review
42
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Selective Serotonin Reuptake Inhibitors
100%
Neonatal Abstinence Syndrome
100%
During Pregnancy
20%
Clinical Syndromes
20%
First Day
20%
Gastrointestinal
20%
Prolonged Exposure
20%
Newborn Infant
20%
Clinical Signs
20%
Childbearing Women
20%
Postpartum Period
20%
Non-specific Symptoms
20%
Finnegan Scores
20%
Central Nervous System Depression
20%
Medicine and Dentistry
Selective Serotonin Reuptake Inhibitor
100%
Neonatal Abstinence Syndrome
100%
Neonatal Infant
40%
Clinical Syndrome
20%
Long Term Exposure
20%
Puerperium
20%
Central Nervous System Depression
20%
Pharmacology, Toxicology and Pharmaceutical Science
Selective Serotonin Reuptake Inhibitor
100%
Neonatal Abstinence Syndrome
100%
Syndrome
20%
Long Term Exposure
20%